At the conclusion of this activity, learners should be able to:
- Understand the role of EGFR in lung cancer
- Know the discovery of EGFR mutations in NSCLC
- Recognize secondary and tertiary EGFR mutations
- Distinguish small cell transformation
- Introduce the pathology workflow for the EGFR-mutant NSCLC
Add to calendar:
Session date:
10/01/2021 - 12:00pm to 1:00pm EDT
Room Number:
Zoom Meeting
Speaker Name:
Weiwei Shi, MD, PhD